Roche

Digital Pathology

Roche Expands Access to Cervical Cancer Screening Tools with Two New WHO Prequalification Designations, Including HPV Self-Collection

The World Health Organization (WHO) has awarded Roche’s human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System and for self-collected samples on the cobas...

Roche Diagnostics, Ventana, Slide Scanner, Digital pathology

Seeing Cancer with Color: Spectroscopic Imaging Platform Maps Tumor Landscape

by Christos Evangelou, MSc, PhD – Medical Writer and Editor Cancer cells avoid detection by shielding themselves behind a complex molecular barricade of normal cells. This impenetrable tumor microenvi...

PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics

Relationship Aims to Uniquely Support Biopharma Companies in Advancing Precision Medicine Boston, MA – February 13, 2024 – PathAI Inc., a leading AI-powered pathology company, today announced an expan...

Roche Collaborates With Ibex And Amazon Web Services To Accelerate Adoption Of AI-enabled Digital Pathology Solutions To Help Improve Cancer Diagnoses

Roche’s navify Digital Pathology software platform now offers Ibex’s Artificial Intelligence (AI) algorithms to support clinicians in the diagnosis of breast and prostate cancer. Roche and Ibex cloud-...

Roche announces Brad Moore as president and CEO of Roche Diagnostics North America

Roche have announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Poi...

Roche introduces the Navify brand for its digital health solutions at HLTH 2022

Roche unifies its digital health portfolio under the navify brand, providing a range of next generation software solutions. The navify portfolio uses digital solutions, analytics and data science to p...